Straumann® 牙科植體系統的表面 

化不可能為可能。

從行業標桿 SLA® 到高效能 SLActive® 植體表面,Straumann 不斷提高要求以建立骨整合的新標準。為 Straumann® PURE 全陶瓷植體而開發的 ZLA® 延續了這一傳統。

纖維蛋白網的 SEM 圖片,由 Empa 提供,拍攝於 2016 年

Straumann® SLActive®

效能超乎想象。

SLActive® 是 Straumann 推出的具有強大促癒合潛力的高效能表面。它代表著高度的可預測性和快速的骨整合1-8。 最近的研究顯示,即使面對難度極高的治療方案和健康狀況不佳的患者,SLActive® 植體也能表現出非凡的臨床效能。9-11

  • 可預測性

    即刻負載植體的 10 年期存活率:98.2%9

  • 骨整合

    在所有適應症中,癒合期從 6-8 週縮短至 3-4 週。*

  • 生物學

    即使在狀況複雜的部位也能促進骨再生。12

  • 效能

    在接受過放射治療的骨狀況不良患者中 5 年後植體存活率:100%10,11

* 與 SLA® 相比。適應症:從單顆缺牙到無牙頜。

我們可以為您提供哪些幫助?

纖維蛋白網的 SEM 圖片,由 Empa 提供,拍攝於 2016 年

Straumann® SLA®

每天的醫療都是完成持久耐用且高效。

經典的 SLA® 表面於 1998 年推出,以大顆粒噴砂工藝為基礎,形成大粗糙度的鈦表面。之後又透過酸蝕打造微粗糙度外層。得到的表面形貌是供細胞附著的理想結構。大量經專家審批的臨床和臨床前研究都已證實其強大的長期效能和可靠性,因此它是牙科種植領域中有文獻證實的最佳表面之一。根據一項獨立研究,使用其他競爭品牌植體系統的患者發生植體周圍炎的風險,比使用 SLA® 表面的 Straumann® 植體的患者要高三倍多。13

  • 存活率

    經過 5 年和 10 年跟進後,不同的研究一致證實其存活率極高,介於 95.1% 和 98.8% 之間。14-20

  • 骨質保存

    10 年後平均骨吸收量為 0.5-1 mm(以植體負載時間為基線)。15,16

  • 植體周圍炎患病率低

    10 年跟進期內植體周圍炎患病率極低 (1.8%)。15

我們可以為您提供哪些幫助?

Straumann® ZLA®

具有革命性骨整合效能的表面。

Straumann® ZLA® 是 Straumann® PURE 全陶瓷植體系統的表面,並具有與成熟的原裝 Straumann® SLA® 表面同等的革命性骨整合效能。 

  • 結構

    大粗糙度和微粗糙度類似於 SLA®。

  • 骨整合

    癒合時間與 SLA® 相當。21-23

  • 美學

    更少牙菌斑附著 – 這是維持植牙長期成功的重要因素23

聯絡我們

資料使用協議*

請閱讀我們的隱私權政策

請重新輸入上述驗證碼

下載

文件

Discover natural PURE white. Love your smile.

Straumann® PURE Ceramic Implant System - low-res
490.281/en/A/00 01/17 31.01.2017 PDF, 3 MB 下载

More than a unique implant surface.

Straumann® SLActive®
152.917/en/B/01 02/15 28.02.2015 PDF, 1 MB 下载

Performance beyond imagination.

Straumann® SLActive®
490.026/en/D/00 09/17 30.09.2017 PDF, 2 MB 下载
查看所有资源...

影片與動畫

SLActive®. The concept of hydrophilicity

SLActive® / SLA®
V0012-en 23.05.2017 M4V

Straumann® SLActive®

Performance data and testimonials
V0025-en 23.05.2017 M4V
查看所有资源...

科學證據

Straumann® PURE Ceramic Implant System

Clinical review - low-res
490.059/en/B/00 04/19 26.04.2019 PDF, 866 KB 下载

Straumann® SLActive®

Clinical Review
490.259/en/A/00 10/16 31.10.2016 PDF, 438 KB 下载

Straumann® SLA® implant surface

Scientific Review
01/14 490.010/en/A/000 31.01.2014 PDF, 1 MB 下载

Straumann® Bone Level SLActive® Implants

Scientific Review
490.009/en/A000 01/14 31.01.2014 PDF, 478 KB 下载

查看 SLActive®  和 SLA® 的精選科學文獻

目錄

Product Catalog 2019/2020

Straumann International Edition
452.200/en/D/00 07/19 28.06.2019 PDF, 15 MB 下载

Product Catalog 2019

Straumann® BLX Implant System - interactive
450.012/en/B/00 02/19 26.03.2019 PDF, 2 MB 下载
查看所有资源...

參考文獻

SLActive® 1 Straumann SLActive implants compared to Straumann SLA implants.Lang NP, Salvi GE, Huynh-Ba G, Ivanovski S, Donos N, Bosshardt DD.Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans.Clin Oral Implants Res.2011 Apr;22(4):349-56. doi: 10.1111/j.1600-0501.2011.02172.x.2 Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstorfer J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces.Journal of Biomedical Materials Research A, 76(2):323-334, 2006. 3 De Wild M. Superhydrophilic SLActive® implants.Straumann document 151.52, 2005; Katharina Maniura.Laboratory for Materials – Biology Interactions Empa, St. Gallen, Switzerland, Protein and blood adsorption on Ti and TiZr implants as a model for osseointegration.EAO 22nd Annual Scientific Meeting, October 17 – 19 2013, Dublin.Kopf BS, Schipanski A, Rottmar M, Berner S, Maniura-Weber K, Enhanced differentiation of human osteoblasts on Ti surfaces pre-treated with human whole blood.Acta Biomaterialia.2015 June; 19: 180-190.Kopf BS, Ruch S, Berner S, Spencer ND, Maniura-Weber K, The role of nanostructures and hydrophilicity in osseointegration: In-vitro protein-adsorption and blood-interaction studies.J Biomed Mater Res A. 2015 August; 103 (8): 2661-2672. 4 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA® titanium implants: an immunohistochemical study in dogs.J Clin.Periodontol.35.1 (2008): 64-75.5 Rausch-fan X, Qu Z, Wieland M, Matejka M, Schedle A. Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces.Dental Materials 2008 Jan;24(1):102-10.Epub 2007 Apr 27.6 Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA® titanium implants: Preliminary results of a pilot study in dogs.Clinical Oral Implants Research, 11(4): 481-488, 2007.7 Raghavendra S, Wood MC, Taylor TD.Int. J. Oral Maxillofac.Implants.2005 May–Jun;20(3):425–31.9.8 Oates TW, Valderrama P, Bischof M, Nedir R, Jones A, Simpson J, Toutenburg H, Cochran DL.Enhanced implant stability with a chemically modified SLA® surface: a randomized pilot study.Int. J. Oral Maxillofac.Implants.2007;22(5):755-760.9 Nicolau P, Guerra F, Reis R, Krafft T, Benz K , Jackowski J 10-year results from a randomized controlled multicenter study with immediately and early loaded SLActive implants in posterior jaws.Presented at 25th Annual Scientific Meeting of the European Association of Osseointegration – 29 Sep – 1 Oct 2016, Paris.10 Nelson, K., Stricker, A., Raguse, J.-D. and Nahles, S. (2016), Rehabilitation of irradiated patients with chemically modified and conventional SLA implants: a clinical clarification.J Oral Rehabil, 43: 871–872. doi:10.1111/joor.12434.11 Patients treated with dental implants after surgery and radio-chemotherapy of oral cancer.Heberer S, Kilic S, Hossamo J, Raguse J-D, Nelson K. Rehabilitation of irradiated patients with modified and conventional sandblasted, acid-etched implants: preliminary results of a split-mouth study.Clin.Oral Impl.Res.22, 2011; 546–551.12 Straumann (2016).SLActive® supports enhanced bone formation in a minipig surgical GBR model with coronal circumferential defects.Unpublished data. SLA® 13 Buser D, Janner SF, Wittneben JG, Bragger U, Ramseier CA, Salvi GE.10-year survival and success rates of 511 titanium implants with a sandblasted and acid-etched surface: a retrospective study in 303 partially edentulous patients.Clin Implant Dent Relat Res.2012 Dec;14(6):839-51.14 Fischer K, Stenberg T.: Prospective 10-year cohort study based on a randomized controlled trial (RCT) on implant-supported full-arch maxillary prostheses.Part 1: sandblasted and acid-etched implants and mucosal tissue.Clin Implant Dent Relat Res.2012 Dec;14(6):808-15.15 van Velzen FJ, Ofec R, Schulten EA, Ten Bruggenkate CM,.10-year survival rate and the incidence of peri-implant disease of 374 titanium dental implants with a SLA surface: a prospective cohort study in 177 fully and partially edentulous patients.Clin Oral Implants Res.2015 Oct;26(10):1121-8.16 Cochran DL, Jackson JM, Bernard JP, ten Bruggenkate CM, Buser D, Taylor TD, Weingart D, Schoolfield JD, Jones AA, Oates TW Jr. A 5-year prospective multicenter study of early loaded titanium implants with a sandblasted and acid-etched surface.Int J Oral Maxillofac Implants.2011 Nov-Dec;26(6):1324-32.17 Cochran D, Oates T, Morton D, Jones A, Buser D, Peters F. Clinical field trial examining an implant with a sand-blasted, acid-etched surface.J Periodontol.2007 Jun;78(6):974-82.18 Bornstein MM, Schmid B, Belser UC, Lussi A, Buser D. Early loading of non-submerged titanium implants with a sandblasted and acid-etched surface.5-year results of a prospective study in partially edentulous patients.Clin Oral Implants Res.2005 Dec;16(6):631-8.19 Roccuzzo M1, Aglietta M, Bunino M, Bonino L. Early loading of sandblasted and acid-etched implants: a randomized-controlled double-blind split-mouth study.Five-year results.Clin Oral Implants Res.2008 Feb;19(2):148-52.20 Derks J, Schaller D, Håkansson J, Wennström JL, Tomasi C, Berglundh T. Effectiveness of Implant Therapy Analyzed in a Swedish Population: Prevalence of Peri-implantitis.J Dent Res.2016 Jan;95(1):43-9. doi ZLA® 21 Bormann KH, Gellrich NC, Kniha H, Dard M, Wieland M, Gahlert M. Biomechanical evaluation of a microstructured zirconia implant by a removal torque comparison with a standard Ti-SLA implant.Clin Oral Implants Res.2012 Oct;23(10):1210-6. doi: 10.1111/j.1600-0501.2011.02291.x.Epub 2011 Nov 14. 22 Gahlert M, Roehling S, Sprecher CM, Kniha H, Milz S, Bormann K. In vivo performance of zirconia and titanium implants: a histomorphometric study in mini pig maxillae.Clin Oral Implants Res.2012 Mar;23(3):281-6. doi: 10.1111/j.1600-0501.2011.02157.x.Epub 2011 Aug 2.23 Gahlert M1, Röhling S, Wieland M, Eichhorn S, Küchenhoff H, Kniha H A comparison study of the osseointegration of zirconia and titanium dental implants.A biomechanical evaluation in the maxilla of pigs.Clin Implant Dent Relat Res.2010 Dec;12(4):297-305. doi: 10.1111/j.1708-8208.2009.00168.x.

ZLA® 23 Roehling S, Astasov-Frauenhoffer M, Hauser-Gerspach, Braissant O, Woelfler H, et a., In Vitro Biofilm Formation On Titanium And Zirconia Implant Surfaces, J Periodontol.2016 Oct 7:1-16.[Epub ahead of print] DOI: 10.1902/jop.2016.160245